Anaerobic and microaerophilic organism DNA

Anaerobic and microaerophilic organism DNA is the primary molecular target for the nitroimidazole class of antibiotics, including metronidazole and tinidazole [1]. These organisms possess unique metabolic pathways, such as the pyruvate:ferredoxin oxidoreductase system, which can reduce the nitro group of the drug into highly reactive nitro radical anions [2]. These radicals interact directly with the microbial DNA, causing a loss of helical structure, strand breakage, and subsequent inhibition of nucleic acid synthesis [3]. This targeted damage leads to rapid cell death in susceptible anaerobic bacteria and certain protozoa [1]. Because aerobic cells and mammalian hosts lack the necessary low-redox potential electron transport components to activate the drug, this mechanism provides high selectivity for anaerobic and microaerophilic pathogens [4]. This target is clinically significant for treating infections like bacterial vaginosis, amoebiasis, and Clostridioides difficile-associated diarrhea [1]. Resistance can occur through mutations in genes encoding the activating enzymes, reducing the drug's ability to damage the DNA [2]. Overall, the destruction of this DNA target is the cornerstone of therapy for serious anaerobic infections.

Other names

Bacterial DNAMicrobial DNAAnaerobic bacterial DNA

Reductive activation of the nitro group by microbial electron transport proteins (like ferredoxin) generates reactive intermediates that cause DNA strand breakage and helical destabilization [1][2].